| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 01/24/2007 | CN1900073A Process for preparing N-phenyl-2-pyrimidyl amine derivative |
| 01/24/2007 | CN1900063A Symmetrical diazo compounds, compositions comprising them, method for coloring, and device |
| 01/24/2007 | CN1900062A Process for the preparation of nicotinic acid |
| 01/24/2007 | CN1296357C Heteroaryl-substituted aminocyclohexane derivatives |
| 01/24/2007 | CN1296346C Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical |
| 01/23/2007 | US7166746 Fungicides for controlling and preventing an infestation of crop plants by phytopathogenic microorganisms; 2-hydroxy-N-[trans-2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-cyclohexyl]-2-phenyl-acetamide |
| 01/23/2007 | US7166745 Acyclic and macrocyclic, aliphatic diammonium surfactants for use in forming lipid aggregates for drug delivery of macromolecules; improved versatility among different cell types and broadened range of molecules to be carried |
| 01/23/2007 | US7166726 Aryl substituted 3,4-dihydroanthracene derivatives having retinoid antagonist or retinoid inverse agonist type biological activity |
| 01/23/2007 | US7166724 Ionic liquids |
| 01/23/2007 | US7166638 Statin derivatives |
| 01/23/2007 | US7166621 E.g 2-(5-chloro-3-pyridyloxy)-N-(2-methylpent-3-yn-2-yl)butyramide; 2-(5chloro-3-pyridyloxy)-N-(4methylhex-2-yn-4-yl)butyramide; 2-(5chloro-3-pyridyloxy)-N-(2-methylpent-3-yn-2-yl)valeramide |
| 01/23/2007 | US7166601 A phenylamide derivatives for treating gastrointestinal reflux disorders, eating disorder obesity and irritable bowel disorder |
| 01/23/2007 | US7166593 Glucocorticoid receptor modulators |
| 01/23/2007 | US7166590 Antiischemic agents; cardiovascular disorders |
| 01/23/2007 | US7166368 A platinum complexes containing a 2,4-pentanedionate group and pyridyl group, maxima spectral emittance |
| 01/23/2007 | US7166240 Luminescent efficiency and a long luminescent life |
| 01/23/2007 | CA2493275C Processes for the preparation of triazinone derivatives |
| 01/23/2007 | CA2332188C 5-(1-aminocyclohexyl)-2(1h)-pyridinone compounds and intermediates in the production thereof |
| 01/23/2007 | CA2329193C Process for synthesizing cox-2 inhibitors |
| 01/23/2007 | CA2273156C Novel 2-fluoroacrylic acid derivatives, novel mixtures of herbicides and antidotes and their use |
| 01/23/2007 | CA2101104C Amino acid linked nitrogen mustard derivatives and their use as prodrugs in the treatment of tumors |
| 01/18/2007 | WO2007007886A1 An oxime derivative and preparations thereof |
| 01/18/2007 | WO2007007018A1 Piperazine heteroaryl derivates as gpr38 agonists |
| 01/18/2007 | WO2007006594A2 Reactive azo dyes, methods for the production thereof and their use |
| 01/18/2007 | WO2007006547A1 Amide derivatives as kinase inhibitors |
| 01/18/2007 | WO2007006546A1 Amide derivatives as kinase inhibitors |
| 01/18/2007 | WO2007006459A1 Heteroarylethenyl derivatives, their manufacture and use as pharmaceutical agents |
| 01/18/2007 | WO2007006387A2 Onium-alkylsulfonate production method |
| 01/18/2007 | WO2006115895A3 Phenyl ethyne compounds |
| 01/18/2007 | WO2006083930A3 Derivatives of 4-demethylpenclomedine, use thereof and preparation thereof |
| 01/18/2007 | WO2005005376A8 Fungicidal phenoxyphenylhydrazine derivatives |
| 01/18/2007 | US20070015918 Derivatives of 1,3-diones having a herbicidal activity |
| 01/18/2007 | US20070015800 Use of a compound in providing refreshedness on waking and a method for the treatment of drowsiness therewith |
| 01/18/2007 | US20070015799 Glyoxalase inhibitors |
| 01/18/2007 | US20070015794 Endothelial growth factor; angiogenesis inhibitors; antitumor agents; skin disorders; endimetriosis; Crohn's disease; leukemia; antiarthritic agents |
| 01/18/2007 | US20070015762 NPY Y5 antagonist |
| 01/18/2007 | US20070015755 Novel compounds and compositions as protease inhibitors |
| 01/18/2007 | US20070015687 Synergistic pharmaceutical combination for the prevention or treatment of diabetes |
| 01/18/2007 | DE102005032836A1 Verfahren zur Herstellung von Onium-Alkylsulfonaten A process for the preparation of onium alkylsulfonates |
| 01/18/2007 | CA2614930A1 Glutamate aggrecanase inhibitors |
| 01/18/2007 | CA2613458A1 Compounds with activity at retinoic acid receptors |
| 01/18/2007 | CA2612752A1 Heteroarylethenyl derivatives, their manufacture and use as pharmaceutical agents |
| 01/17/2007 | EP1743885A2 TNF-Alpha Produktion Hemmer zur Behandlung von Autoimmunerkrankungen |
| 01/17/2007 | EP1742927A1 Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof |
| 01/17/2007 | EP1742917A1 Use of pyridindione derivatives for protecting organic material against detrimental effects of light |
| 01/17/2007 | EP1742916A1 Phenyl compounds and their use in the treatment of conditions mediated by the action of pge2 at the ep1 receptor |
| 01/17/2007 | EP1742915A2 Tetrahydropyranyl cyclopentyl tetrahy-dropyridopyridine modulators of chemokine receptor activity |
| 01/17/2007 | EP1742908A1 Non-nucleoside reverse transcriptase inhibitors |
| 01/17/2007 | EP1742907A2 Certain chemical entities, compositions, and methods |
| 01/17/2007 | EP1742707A2 Treatment of cns disorders using cns target modulators |
| 01/17/2007 | EP1742642A2 Phosphonate analogs of hiv integrase inhibitor compounds |
| 01/17/2007 | EP1742635A2 Substituted organosulfur compounds and methods of using thereof |
| 01/17/2007 | EP1400518B1 Heterocyclic compound derivatives and medicines |
| 01/17/2007 | CN1898255A Process for the preparation of pyridine derivatives |
| 01/17/2007 | CN1898234A Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases |
| 01/17/2007 | CN1898213A Heteroaroyl-substituted phenylalanineamides with herbicidal action |
| 01/17/2007 | CN1898210A 2-pyridinylethylcarboxamide derivatives and their use as fungicides |
| 01/17/2007 | CN1898209A Pyridine carboxylic acid derivatives as glucokinase modulators |
| 01/17/2007 | CN1898208A Amide derivative and medicine |
| 01/17/2007 | CN1898207A 2-pyridinylethylbenzamide derivatives |
| 01/17/2007 | CN1898201A Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents |
| 01/17/2007 | CN1898199A Phenylamide and pyridylamide beta-secretase inhibitors for the treatment of alzheimer's disease |
| 01/17/2007 | CN1898198A Alpha-hydroxy amides as bradykinin antagonists or inverse agonists |
| 01/17/2007 | CN1898187A Fluorinating agent and method for producing fluorine-containing compound using same |
| 01/17/2007 | CN1897944A Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-hsd-1) for the treatment of diabetes and obesity |
| 01/17/2007 | CN1897939A Phenoxyacetic acids derivatives useful as peroxisome proliferator-activated receptor (ppar) dual agonists |
| 01/17/2007 | CN1896074A Fluorescent molecular probe and use for inspecting transient metal and heavy metal ion |
| 01/17/2007 | CN1896073A New phenylpyridylpiperazine compounds, a process for their preparation and pharmaceutical compositions containing them |
| 01/17/2007 | CN1896070A 2- and 2,5-substituted phenylketo-enols |
| 01/17/2007 | CN1896062A New phenylpyridylpiperazine compounds, a process for their preparation and pharmaceutical compositions containing them |
| 01/17/2007 | CN1896061A Self-assembled molecular-based and high-diameter-ratio organic wire and its production |
| 01/17/2007 | CN1295221C Substituted heterocyclic compounds |
| 01/16/2007 | US7164020 Preparation of metal amide complexes |
| 01/16/2007 | US7163957 anti-psychotic; selectively interact with the dopaminergic receptors of the D2/D3 subtypes and the serotoninergic receptors of the 5-HT1A subtype at the level of which they behave as antagonists and agonists, respectively |
| 01/16/2007 | US7163951 N-biarylmethyl aminocycloalkanecarboxamide derivatives |
| 01/16/2007 | US7163938 Substituted carboxamides |
| 01/16/2007 | CA2257234C Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
| 01/16/2007 | CA2221397C Process for the production of aromatic halogen-amino compounds |
| 01/16/2007 | CA2208746C Novel immunotherapeutic aryl amides |
| 01/11/2007 | WO2007004543A1 Pharmaceutical composition comprising 2-pyridone derivative as active ingredient |
| 01/11/2007 | WO2007003982A1 Improved process for the manufacture of flecainide |
| 01/11/2007 | WO2007003965A1 Substituted cyclohexyl derivatives as nk-3 receptor antagonists |
| 01/11/2007 | WO2007003944A2 Compounds for imaging and therapy |
| 01/11/2007 | WO2007003604A2 Hists1mine h3 receptor antagonists |
| 01/11/2007 | WO2007003581A1 Phenoxy acetic acids as ppar delta activators |
| 01/11/2007 | WO2006118955A3 Process for preparing 3,3-disubstituted oxindoles and thio-oxindoles |
| 01/11/2007 | WO2006084369A9 Diamine calcium channel blockers |
| 01/11/2007 | WO2005079270A3 2-substituted and 4-substituted aryl nitrone compouds |
| 01/11/2007 | US20070010674 Method of synthesizing camptothecin-relating compounds |
| 01/11/2007 | US20070010673 Purification means |
| 01/11/2007 | US20070010669 Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof |
| 01/11/2007 | US20070010564 Antiproliferative agent; antitumor, anticancer; 2-Thiophen-2-yl-ethenesulfonic acid benzoylamides; reaction of the halogenated heteroaryl ring with ethenesulfonic acid (1,1,3,3-tetramethyl-butyl)-amide, dealkylation, then benzoylation |
| 01/11/2007 | US20070010563 Novel methods for the treatment of inflammatory diseases |
| 01/11/2007 | US20070010562 Nr1h4 nuclear receptor binding compounds |
| 01/11/2007 | US20070010558 Opioid receptor antagonists |
| 01/11/2007 | US20070010554 Aryl substituted pyridines and the use thereof |
| 01/11/2007 | US20070010536 Selectively inducing terminal differentiation of neoplastic cells; antiproliferative agents; antineoplastic agents; antitumor agents; melanomes; acute leukemia, multiple myeloma; carcinomas; neuroblastoma; N-t-butoxycarbonyl- omega -methyl - alpha -aminosuberateanilide |
| 01/11/2007 | US20070010521 Condensed polycyclic compounds |
| 01/11/2007 | US20070010489 Saquinavir-like, a Lopinavir-like, a Ritonavir-like, a Indinavir-lik, a atazanavir-like, Nelfinavir-like.a Tipranavir-like, a Amprenavir-like, a KNI-like. a cyclic carbonyl-like phosphonate HIV protease inhibitors; drug designing |
| 01/11/2007 | US20070010453 Prodrugs of GABA analogs, compositions and uses thereof |